NCT03049891

Brief Summary

The decentralization study will describe children taking antiretroviral therapy (ART) at a larger health facility in the Eastern Cape province of South Africa, between the years of 2004-2013. The study will be conducted at Dora Nginza Hospital (DNH). The study will measure how many children stay in care and how many die, as well as their health status. The study will also compare whether children do better if they stay in care a large hospitals or if they get health care at smaller clinics. A second part of the study will find children in the community who have stopped coming for health care and find out what happened to them and what their health status is.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,583

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2015

Shorter than P25 for all trials

Geographic Reach
1 country

15 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 6, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 10, 2017

Completed
Last Updated

February 10, 2017

Status Verified

February 1, 2017

Enrollment Period

4 months

First QC Date

February 6, 2017

Last Update Submit

February 8, 2017

Conditions

Keywords

Antiretroviral TherapyRetentionLoss to Follow Up

Outcome Measures

Primary Outcomes (1)

  • Proportion of children initiated on ART at DNH who are still in care

    Baseline (single measure)

Secondary Outcomes (3)

  • Proportion of children with hospitalization and/or death after ART initiation at DNH

    Baseline (single measure)

  • Proportion of down-referred children retained in care at their down-referral facility.

    Baseline (single measure)

  • Proportion of children who died or were LTF among those who remained at DNH and those down-referred

    Baseline (single measure)

Study Arms (4)

Children down-referred from DNH

This group includes children who were transferred from DNH to a study facility. The investigators will first abstract data from the electronic data system 'Tier.net' for these children, which will tell us where they were down-referred. For children who were labeled as down-referred from DNH in Tier.net, data abstraction of the child's clinical data will be conducted at the down-referral site and from the National Health Laboratory Service (NHLS) data.

Other: Data abstractionOther: Tier.net

Children LTF from DNH

This group includes children who began ART at DNH and were subsequently LTF. The investigators will first abstract data from the electronic data system 'Tier.net', which will classify them as LTF followed by examination of the the NHLS laboratory data to determine whether these children had received care at another facility since they were LTF.

Other: Data abstractionOther: Tier.net

Caregivers of LTF

This group includes the caregivers of a subset of children in the 'LTF from DNH' and 'down-referred from DNH' groups. Among those children down-referred and LTF from DNH, the investigators will use their clinical and laboratory data to determine whether they are still receiving care or not. For children identified as LTF based on their abstracted data will be traced in order to contact their caregivers. If located, caregivers will be interviewed to ascertain if and why these children are no longer in care through a 'Tracing questionnaire'.

Other: Tracing questionnaire

DNH only

This group includes children who are still in care at DNH, died while in care at DNH, or were transferred to facilities from tier.net will not have any additional information collected other than what is recorded in the Tier.net database.

Other: Tier.net

Interventions

The investigators will abstract clinical data from down-referral sites and from NHLS to determine whether children made it to their down-referral sites or whether children are in care at a different facility.

Also known as: NHLS (National Health Laboratory Service)
Children LTF from DNHChildren down-referred from DNH

The investigators will attempt to contact and visit caregivers of children who are determined to be LTF from DNH or from down-referral sites. If located and after providing consent, caregivers will be administered a tracing questionnaire, or a verbal autopsy if their child has died.

Caregivers of LTF

For all children who started ART at DNH between 2004 and 2013, the investigators will abstract data on these children from the electronic medical system in South Africa called Tier.net.

Children LTF from DNHChildren down-referred from DNHDNH only

Eligibility Criteria

AgeUp to 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

This study consists of two parts. The first part is a retrospective records review of electronic and medical records of children starting ART at a large hospital facility 2004-2013 (no sampling or recruitment). We expect that 1600 children started ART during this period. The second part of the study will be a community tracing study of children who have been lost to follow-up, in which we will interview caregivers of children. We will randomly sample 75 patients who have been LTF will be generated using the data from the retrospective records review.

You may qualify if:

  • HIV positive; less than 15 years of age; started ART at DNH between 2004 and 2013.

You may not qualify if:

  • Tracing Study:
  • Legal caregiver (older than 18) a child who was included in the ART Outcomes Study that was found to be LTFU from DNH or from the down-referral facility.
  • Guardians who cannot be confirmed as the legal caregiver of the child

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (15)

Chatty Clinic

Port Elizabeth, Eastern Cape, South Africa

Location

Dora Nginza Hospital

Port Elizabeth, Eastern Cape, South Africa

Location

Empilweni TB Hospital

Port Elizabeth, Eastern Cape, South Africa

Location

Govan Mbeki Clinic

Port Elizabeth, Eastern Cape, South Africa

Location

Joe Slovo Clinic

Port Elizabeth, Eastern Cape, South Africa

Location

Kwadwesi Clinic

Port Elizabeth, Eastern Cape, South Africa

Location

Kwazakhele Clinic

Port Elizabeth, Eastern Cape, South Africa

Location

Kwazakhele Community Health Center

Port Elizabeth, Eastern Cape, South Africa

Location

Motherwell Community Health Center

Port Elizabeth, Eastern Cape, South Africa

Location

New Brighton Clinic

Port Elizabeth, Eastern Cape, South Africa

Location

New Brighton Community Health Center

Port Elizabeth, Eastern Cape, South Africa

Location

Soweto Clinic

Port Elizabeth, Eastern Cape, South Africa

Location

Walmer 14th Avenue Clinic

Port Elizabeth, Eastern Cape, South Africa

Location

West End Clinic

Port Elizabeth, Eastern Cape, South Africa

Location

Zwide Clinic

Port Elizabeth, Eastern Cape, South Africa

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Elaine J Abrams, MD

    ICAP at Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Director, ICAP at Columbia University

Study Record Dates

First Submitted

February 6, 2017

First Posted

February 10, 2017

Study Start

November 1, 2015

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

February 10, 2017

Record last verified: 2017-02

Locations